Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-16

Clinical Trial Update: Long-term Efficacy of Modified Guilu Erxian Glue for Myasthenia Gravis

View source ↗

Summary

This document reports on the completion and long-term efficacy data from a clinical trial evaluating Modified Guilu Erxian Glue for Myasthenia Gravis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Modified Guilu Erxian Glue

Snippet

Sponsor: Beijing University of Chinese Medicine | Conditions: Myasthenia Gravis (MG) | Status: COMPLETED